Opening Keynote
AI in Critical Care: The New Horizon
Azra Bihorac, MD, MS, FCCM, FASN
Wednesday, August 16 | 8:00 a.m. - 9:45 a.m. MST
Keynote Description
Because of the vast workload and patient data flow within critical care units, artificial intelligence and machine learning algorithms can be valuable tools for updating clinicians in real-time on their patients’ acuity and predicted trajectory. By using sensing technologies along with deep learning to integrate clinical and physiological data with real time autonomous assessment of visual cues, AI models can provide clinicians with continuously updated risk assessment and phenotyping for patients.
Learning Objectives
- Discuss and analyze recent advancements for AI in critical care.
- Analyze the value of pervasive sensing in critical care.
- Examine the benefits of phenotyping in critical care.
- Evaluate the next steps for advancing AI research in critical care.
About Dr. Bihorac
Azra Bihorac, MD, MS, FASN, FCCM, is the senior sssociate dean of research at the University of Florida College of Medicine. She is the R. Glenn Davis Professor of Medicine, Surgery, Anesthesiology, and Physiology & Functional Genomics; the lab Ddirector of Precision and Intelligent Systems in Medicine Research Partnership (PRISMAP); and the director of the Intelligent Critical Care Center (IC3), a multi-disciplinary center focused on developing and providing sustainable support and leadership for transformative medical AI research, education, and clinical applications to advance patients’ health in critical and acute care medicine.
Her work with IC3 addresses an unprecedented opportunity for world-leading ambient, immersive and artificial intelligence research and innovation, to transform the diagnosis, monitoring and treatment for critically and acutely ill patients using the multimodal clinical and research data and resources stemming from UF Health, one of the Florida’s largest health care systems. Dr. Bihorac's vision is to develop tools for intelligent human-centered health care that delivers optimized care tailored to a patient’s “personal clinical profile” using digital data. Through her work in national and international professional organizations in nephrology and critical care medicine, she has advocated for women physicians and scientists, promoting their equality and recognition in health care leadership, research and education.
Inclusion in Neurocritical Care (INCC) Keynote
The Impact of the Changing Landscape of Patient Autonomy on Health Care Disparities in Neurocritical Care
Monisha Kumar, MD
Thursday, August 17 | 8:00 a.m. - 9:00 a.m. MST
Keynote Description
The current political landscape has restricted access to health care for marginalized and minoritized populations, impeding patient autonomy, one of the foundational tenets of medical practice in the United States. Similar views may threaten determination of brain death and ultimately compromise organ transplantation further disenfranchising transplant recipients, the majority of whom are of minoritized populations. Learn why this may be broadly relevant to providers as well as patients in the NCS.
Learning Objectives
- To recognize the impact of current political and social factors on patient autonomy, particularly for marginalized and minoritized populations in neurocritical care.
- To understand the potential consequences of compromised patient autonomy on the determination of brain death and organ transplantation, with attention to its impact on minoritized populations.
- To review the impact of recent and ongoing legal proceedings regarding patient autonomy on health equity.
About Dr. Kumar
Dr. Monisha Kumar is a neurointensivist and clinical researcher whose area of expertise is in coagulation derangements associated with severe brain injury. She is triple boarded in neurology, vascular neurology and neurocritical care. She is an associate professor of neurology, neurosurgery, anesthesiology and critical care, vice chair of quality for the Department of Neurology, director of the Neuro-ICU at the Hospital of the University of Pennsylvania, departmental diversity search advisor, co-chair of the Intradepartmental Equity Committee and chair of the Penn Forum for Women Faculty. She serves on the NCS Board of Directors, is a member of the Executive Committee and is the board liaison to the Inclusion in Neurocritical Care Committee and prior chair of the Women in Neurocritical Care Subcommittee. She has devoted her life to promoting and advancing women of all stripes.
Closing Panel
Leadership Vision for The Strategic Future of Neurocritical Care
Session Chair: Paul Vespa, MD, FCCM, FAAN, FANA, FNCS
Panelists: Mary Kay Bader, RN, MSN, CCNS, FNCS, FAHA; Thomas Bleck, MD, MCCM, FNCS; Cherylee Chang MD, FCCM, FNCS; David Greer MD, MA, FCCM, FAHA, FNCS, FAAN, FANA and Panos Varelas MD, PhD, FAAN, FNCS
Friday, August 18 | 10:30 a.m. - 12:00 p.m. MST
Session Description
This session provides insight into NCS leadership's view of the society, the neurocritical care landscape and what is to come in the future. The session will feature a visionary presentation of the leadership direction for the society and an in-depth discussion of the challenges facing the NCS, the field and our patients.
Learning Objectives
- To understand the principles guiding the leadership of the NCS.
- To understand emerging challenges and opportunities in education and interprofessional collaboration in neurocritical care.
- To enable member feedback regarding the future horizon of the leadership in neurocritical care.